Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Tofe-ER Tablet

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Tofacitinib (11mg)

Overview Tofe-ER Tablet

Extended-release Tofacitinib tablets manage moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation, also hindering the progression of bone and joint deterioration. Tofacitinib may be administered alone or alongside other medications. The tablets can be ingested with or without food, ideally at the same time daily. Dosage is tailored to individual needs and other concurrent medications, strictly adhering to your physician's instructions. Discontinuing treatment without medical supervision is strongly discouraged, as it could exacerbate your condition. Frequently reported side effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less common, but potentially serious, adverse effects encompass blood clots and gastrointestinal perforations, demanding immediate medical attention. Consult your doctor regarding any concerns about side effects. Pre-treatment blood work may be necessary, and initiation of Tofacitinib is contraindicated during active infections. Prior to commencing therapy, inform your doctor about any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Tofacitinib increases infection susceptibility and may worsen existing infections; therefore, minimize exposure to contagious illnesses (e.g., chickenpox, measles, influenza). This medication is unsuitable for individuals under 18 years of age and should not be used during pregnancy or breastfeeding unless deemed medically necessary by your doctor. Regular check-ups with your physician may be required.

Uses of Tofe-ER Tablet

Management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Major Benefits of Tofe-ER Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Tofe-ER Tablets can be taken with or without food, although consistent timing is recommended.

Common Side effects of Tofe-ER Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Tofe-ER Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Tofe-ER Tablets can be administered with or without food, though consistent timing is recommended.

How Tofe-ER Tablet works:

Tofe-ER tablets function as a Janus kinase inhibitor, suppressing Janus kinase enzyme activity. This mechanism reduces immune system activity and the inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Tofe-ER Tablet and alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tofe-ER Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Consult your physician for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Tofe-ER tablets while breastfeeding is likely inadvisable. Scant available human evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Tofe-ER Tablets.

KidneyKidneyCAUTION

For individuals with severely impaired kidney function, Tofe-ER Tablet requires careful administration. A modified dosage of Tofe-ER Tablet might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with significant hepatic impairment should exercise caution when using Tofe-ER Tablets. Dosage modification of Tofe-ER Tablets may be necessary. Physician consultation is advised.

What if you forget to take Tofe-ER Tablet :

Should you forget a Tofe-ER Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Tofe-ER Tablet

LabelValue
Chemical Category Pyrrolopyrimidine compound
Developing Good Habits No.
Type of Therapy Pain Relievers
Actions JAK inhibitors

FAQs on Tofe-ER Tablet

Tell your doctor about any liver problems before starting Tofe-ER Tablets. Tofe-ER Tablets can sometimes raise liver enzymes, so your liver function should be checked beforehand. While Tofe-ER Tablets may be used in patients with mild to moderate liver impairment, they shouldn't be prescribed for those with severe impairment.
Tofe-ER Tablets may increase your risk of certain cancers, such as lymphoma and skin cancer, by impacting your immune system. Therefore, tell your doctor about any history of cancer.
Tofe-ER Tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. They're used when prior treatments proved ineffective or unsuitable, or if initial drug responses are poor. Tofe-ER Tablets can be administered alone or alongside other medications like methotrexate.
You may begin feeling better within 2 to 8 weeks after starting Tofe-ER Tablets, though full effectiveness may take 3 to 6 months.
Before and during Tofe-ER Tablet treatment, blood tests may be necessary. These tests check for anemia, low white blood cell counts (neutropenia or lymphopenia), high cholesterol, and elevated liver enzymes, helping to monitor for treatment-related problems. Your doctor might also recommend a tuberculosis test beforehand, as Tofe-ER Tablet could worsen existing infections.
Tofe-ER Tablets suppress the immune system, increasing susceptibility to serious infections, including tuberculosis and potentially life-threatening disseminated fungal, bacterial, or viral infections. Hospital treatment is necessary for such infections.
Combining tocilizumab and Tofe-ER Tablet is not recommended. Tofe-ER Tablet's impact on the immune system necessitates avoiding concurrent use with other immunosuppressants. This combination significantly raises your infection risk and could cause additional health problems.
Tofe-ER Tablet
276
MRP 320
13% off